275 related articles for article (PubMed ID: 28419296)
1. Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.
Fukuda A; Minakawa A; Sato Y; Iwakiri T; Iwatsubo S; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2017 Nov; 32(11):1818-1830. PubMed ID: 28419296
[TBL] [Abstract][Full Text] [Related]
2. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
[TBL] [Abstract][Full Text] [Related]
3. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Glomerular Sox9
Prochnicki A; Amann K; Wegner M; Sock E; Pfister E; Shankland S; Pippin J; Daniel C
Am J Pathol; 2018 Nov; 188(11):2529-2541. PubMed ID: 30201496
[TBL] [Abstract][Full Text] [Related]
5. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.
Ding F; Wickman L; Wang SQ; Zhang Y; Wang F; Afshinnia F; Hodgin J; Ding J; Wiggins RC
Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557
[TBL] [Abstract][Full Text] [Related]
6. Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases.
Fukuda A; Sato Y; Shibata H; Fujimoto S; Wiggins RC
Clin Exp Nephrol; 2024 Jun; 28(6):496-504. PubMed ID: 38402504
[TBL] [Abstract][Full Text] [Related]
7. Urine podocyte mRNAs mark progression of renal disease.
Sato Y; Wharram BL; Lee SK; Wickman L; Goyal M; Venkatareddy M; Chang JW; Wiggins JE; Lienczewski C; Kretzler M; Wiggins RC
J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856
[TBL] [Abstract][Full Text] [Related]
8. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
[TBL] [Abstract][Full Text] [Related]
9. Immunoelectron microscopic study on type I, II and III TGF-beta receptors on visceral glomerular epithelial cells in relation to glomerular basement membrane alterations in proteinuric rats.
Fujigaki Y; Watanabe T; Ikegaya N; Yonemura K; Sun DF; Hishida A; Yamamoto T; Kojima K; Nagase M
Nephrol Dial Transplant; 2000 Feb; 15(2):191-9. PubMed ID: 10648664
[TBL] [Abstract][Full Text] [Related]
10. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
11. TJN-331 improves anti-glomerular basement membrane nephritis by inhibiting the production of intraglomerular transforming growth factor-beta1.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(8):1349-54. PubMed ID: 20686230
[TBL] [Abstract][Full Text] [Related]
12. Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis.
Takakura K; Mizukami K; Mitori H; Noto T; Tomura Y
Eur J Pharmacol; 2014 Aug; 737():106-16. PubMed ID: 24858365
[TBL] [Abstract][Full Text] [Related]
13. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
14. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies.
Yang CW; Hsueh S; Wu MS; Lai PC; Huang JY; Wu CH; Hu SA; Chen JF; Huang CC
Nephron; 1997; 77(3):290-7. PubMed ID: 9375822
[TBL] [Abstract][Full Text] [Related]
15. Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker.
Fukuda A; Wickman LT; Venkatareddy MP; Wang SQ; Chowdhury MA; Wiggins JE; Shedden KA; Wiggins RC
Nephrol Dial Transplant; 2012 Nov; 27(11):4079-87. PubMed ID: 22863839
[TBL] [Abstract][Full Text] [Related]
16. Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
Chauveau B; Gibier JB; Olagne J; Morel A; Aydin S; McAdoo SP; Viallet N; Perrochia H; Pambrun E; Royal V; Demoulin N; Kemeny JL; Philipponnet C; Hertig A; Boffa JJ; Plaisier E; Domenger C; Brochériou I; Deltombe C; Duong Van Huyen JP; Buob D; Roufosse C; Hellmark T; Audard V; Mihout F; Nasr SH; Renaudin K; Moktefi A; Rabant M;
Am J Kidney Dis; 2024 Jun; 83(6):713-728.e1. PubMed ID: 38171412
[TBL] [Abstract][Full Text] [Related]
17. Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
Lopes TG; de Souza ML; da Silva VD; Dos Santos M; da Silva WIC; Itaquy TP; Garbin HI; Veronese FV
PLoS One; 2019; 14(6):e0217585. PubMed ID: 31220088
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
19. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
